Hypotriglyceridemic action of omega-3 fatty acids in healthy subjects does not occur by enhanced lipoprotein lipase and hepatic lipase activities.
Single blind administration of EPA-rich omega-3 fatty acids at 3 dose levels of 3g, 6g and 12g/d (each dose lasting 3 weeks was separated by 2 weeks on placebo) lowered plasma TG levels and lecithin cholesterol acyltransferase-molar esterification rate (LCAT-MER) activity (6.12g/d). Lipolytic enzymes activity (LPL and HL) remained unchanged at these doses. Fat malabsorption was unlikely because of unmodified plasma beta-carotene, retinol and alpha-tocopherol levels.